中文 | ENG

第58卷 第1期 2025-1
Ensuring authorship qualification in clinical research articles: A focus on surgical therapy studies

.........................

第58卷 第1期 2025-1
Estimated risk for transfusion of monkeypox contaminated perioperative blood transfusion: A call to action for stronger regulations and testing protocols

.........................

第58卷 第1期 2025-1
Insights into traumatic and crisis surgery: Implications of data analysis in conflict zones

.........................

第58卷 第1期 2025-1
Tongue peeling as an adverse reaction with use of micronized purified flavonoid: A case report

.........................

第58卷 第1期 2025-1
Pilonidal sinus of scrotum: A rare clinical entity

.........................

第58卷 第1期 2025-1
Incidental autopsy finding of retiform hemangioendothelioma of the spleen

.........................

第58卷 第1期 2025-1
Retroperitoneal laparoscopy for hydronephrosis due to multiple fibroepithelial polyps: A case series

.........................

第58卷 第1期 2025-1
Case reports of type 1 cystic biliary atresia—A rare variant of biliary atresia alongwith reviewof literature

.........................

第58卷 第1期 2025-1
The predictors of intraoperative surgical expenses in liver resection for hepatocellular carcinoma

.........................

第58卷 第1期 2025-1
Intracorporeal anastomosis versus extracorporeal anastomosis following laparoscopic right hemicolectomy: Surgical outcomes of a single-center observational study

.........................

第58卷 第1期 2025-1
Quality of life and spiritual health in motorcycle accident survivors: An analysis using the SF-36 Questionnaire and Spiritual Scale

.........................

第58卷 第1期 2025-1
Plastin 3 expression in circulating tumor cells as a predictor of cancer status in patients with prostate cancer

.........................

第57卷 第6期 2024-11
Emerging robot-guided techniques in endodontic microsurgery

.........................

第57卷 第6期 2024-11
Management of subcapsular hematoma after living donor liver transplant

.........................

第57卷 第6期 2024-11
Urethral pseudodiverticulum with left-sided nonfunctioning kidney: Case report

.........................

第57卷 第6期 2024-11
Strategy to minimize surgical defect of dermatofi brosarcoma protuberans

.........................

第57卷 第6期 2024-11
Rapunzel syndrome—An uncommon disease with varied common presentations

.........................

第57卷 第6期 2024-11
Minimally invasive approaches to management of acute necrotizing pancreatitis

.........................

第57卷 第6期 2024-11
Innovative surgical technique: Addressing ethical concerns

.........................

第57卷 第6期 2024-11
Emergency surgery and HIV screening, clinical or universal scenarios?

.........................
登入帳號才能閱讀全文
 
篇名 Efficacy of Autologous Percutaneous Bone Marrow Graft Injection for Treatment of Nonunion of the Tibia
作者 Jiann-Long Jean, Hsiou-Lan Tang, Shyu-Jye Wang, Jhi-Hong Chang, Sung-chun Lin, Chih-Ju Chen, Chi-Jen Yang, Tai-Chang Chern, Hsin-Pai Lee, Chian-Her Lee
卷期/出版年月 34卷6期 (2001/12)
頁次 294-301
摘要 Traditional autologous bone grafting for nonunion is associated with many complications in both donor and recipient sites. This retrospective study investigated the efficacy of autologous percutaneous bone marrow graft injection for treatment of nonunion of the tibia in a series of patients. Fourteen adult patients with fractures of the tibia with nonunion were treated with autologous percutaneous bone marrow graft injection at our hospital from Janauary 1996 to age of the patients was 26.5 years (range, wq to 62 years). The duration of follow up averaged 1 year 8 months and ranged from 12 months to 4 years. The indications for the procedure was the presence of an established traumatic tibial nonunion. The nonunion was classfied as hypertrophic in two patients and atrophic in 12 patients. The mean duration from injury to marrow injection was 1 year (range, 12 to 26 months). The mean duration from the last operation to bone marrow injection was 10.4 months (range, 7 to 16 months. The mean size of the bony defect was 6.5, (range, 3.0 to 36 mm). The mean time from injection of bone marrow to union of the fracture was 6 months (range, 3 to 10 months). Patients received marrow injeted in volumes of 80 to 100 mL obtained using multiple punctures 1 to 2 cm apart along the iliac crest. The mean number of nucleated type cells in the aspirated marrow was 3.6X10000 /mm3(range, 2.9 to 5.2X10000 /mm3). Four patients received repeated injections. Clinical and radiological union. Conclusions:The results of this study suggest that autologous percutaneous bone marrow graft injection is a simple, effective, and safe operative treatment for nonunion of the tibia. Tibial nonunion with an active infection is a contraindication for this procedure.
關鍵詞 bone graft, fracture, nonunion, bone marrow
分類 Original Articles

台灣外科醫學會雜誌 © 2006 Taiwan Surgical Association All Rights Reserved
會 址:台北市南京東路五段 31 號 3 樓
電 話:(02) 2769-7845 傳 真:(02) 2746-7149 Email: journal@surgery.org.tw